IRIS Accounts Production v25.2.0.378 10894990 director 1.1.24 31.12.24 31.12.24 30/9/25 false true false false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh108949902023-12-31108949902024-12-31108949902024-01-012024-12-31108949902022-12-31108949902023-01-012023-12-31108949902023-12-3110894990ns15:EnglandWales2024-01-012024-12-3110894990ns14:PoundSterling2024-01-012024-12-3110894990ns10:Director12024-01-012024-12-3110894990ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3110894990ns10:SmallEntities2024-01-012024-12-3110894990ns10:Audited2024-01-012024-12-3110894990ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3110894990ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3110894990ns10:FullAccounts2024-01-012024-12-311089499012024-01-012024-12-3110894990ns10:RegisteredOffice2024-01-012024-12-3110894990ns5:CurrentFinancialInstruments2024-12-3110894990ns5:CurrentFinancialInstruments2023-12-3110894990ns5:ShareCapital2024-12-3110894990ns5:ShareCapital2023-12-3110894990ns5:SharePremium2024-12-3110894990ns5:SharePremium2023-12-3110894990ns5:RetainedEarningsAccumulatedLosses2024-12-3110894990ns5:RetainedEarningsAccumulatedLosses2023-12-3110894990ns5:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3110894990ns5:LongLeaseholdAssetsns5:LandBuildings2024-01-012024-12-3110894990ns5:FurnitureFittings2024-01-012024-12-3110894990ns5:ComputerEquipment2024-01-012024-12-3110894990ns5:PatentsTrademarksLicencesConcessionsSimilar2023-12-3110894990ns5:PatentsTrademarksLicencesConcessionsSimilar2024-01-012024-12-3110894990ns5:PatentsTrademarksLicencesConcessionsSimilar2024-12-3110894990ns5:PatentsTrademarksLicencesConcessionsSimilar2023-12-3110894990ns5:LongLeaseholdAssetsns5:LandBuildings2023-12-3110894990ns5:PlantMachinery2023-12-3110894990ns5:FurnitureFittings2023-12-3110894990ns5:ComputerEquipment2023-12-3110894990ns5:PlantMachinery2024-01-012024-12-3110894990ns5:LongLeaseholdAssetsns5:LandBuildings2024-12-3110894990ns5:PlantMachinery2024-12-3110894990ns5:FurnitureFittings2024-12-3110894990ns5:ComputerEquipment2024-12-3110894990ns5:LongLeaseholdAssetsns5:LandBuildings2023-12-3110894990ns5:PlantMachinery2023-12-3110894990ns5:FurnitureFittings2023-12-3110894990ns5:ComputerEquipment2023-12-3110894990ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3110894990ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-31
REGISTERED NUMBER: 10894990 (England and Wales)















FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

MEDOVATE LIMITED

MEDOVATE LIMITED (REGISTERED NUMBER: 10894990)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


MEDOVATE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTOR: P J Mehta





REGISTERED OFFICE: 96 Hampstead Avenue
Mildenhall
Suffolk
IP28 7AS





REGISTERED NUMBER: 10894990 (England and Wales)





AUDITORS: Shaw Gibbs (Audit) Limited
Chartered Certified Accountants
Statutory Auditor
Eagle House
28 Billing Road
Northampton
Northamptonshire
NN1 5AJ

MEDOVATE LIMITED (REGISTERED NUMBER: 10894990)

BALANCE SHEET
31 DECEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 22,552 45,103
Tangible assets 5 2,124 1,846
24,676 46,949

CURRENT ASSETS
Stocks 264,161 334,376
Debtors 6 71,422 87,929
Cash at bank and in hand 24,052 212,995
359,635 635,300
CREDITORS
Amounts falling due within one year 7 634,565 38,014
NET CURRENT (LIABILITIES)/ASSETS (274,930 ) 597,286
TOTAL ASSETS LESS CURRENT
LIABILITIES

(250,254

)

644,235

CAPITAL AND RESERVES
Called up share capital 230 230
Share premium 8,919,900 8,919,900
Retained earnings (9,170,384 ) (8,275,895 )
(250,254 ) 644,235

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 29 September 2025 and were signed by:





P J Mehta - Director


MEDOVATE LIMITED (REGISTERED NUMBER: 10894990)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024


1. STATUTORY INFORMATION

Medovate Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Significant judgements and estimates
The preparation of financial statements requires the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the company accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed within the individual accounting policies below.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible fixed assets under the cost model are stated at historical cost less accumulated amortisation and any accumulated impairment losses.

Purchased IP is recognised as an intangible asset when all of the following criteria are demonstrated:

- The product is technically feasible and marketable;
- The company has adequate resources to complete the development of the product;
- It is probable that the asset created will generate future economic benefits.

The purchased IP is amortised on a straight line basis over a useful economic life of 5 years.

MEDOVATE LIMITED (REGISTERED NUMBER: 10894990)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Leasehold improvements - 33% on cost
Fixtures and fittings - 33% on cost
Computer equipment - 33% on cost

Fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses. Where parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items of property, plant and equipment.

Depreciation methods, useful lives and residual values are reviewed at each balance sheet date. The selection of these residual values and estimated lives requires the exercise of judgement. The directors are required to assess whether there is an indication of impairment to the carrying value of assets. In making that assessment, judgements are made in estimating value in use. The directors consider that the individual carrying values of assets are supportable by their value in use.

Stocks
Stocks and work in progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

Financial instruments
Cash and cash equivalents in the balance sheet comprise cash at banks and in hand and short term deposits with an original maturity date of three months or less.

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the statement of comprehensive income under administrative expenses.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


MEDOVATE LIMITED (REGISTERED NUMBER: 10894990)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2023 - 9 ) .

4. INTANGIBLE FIXED ASSETS
Purchased
IP
£   
COST
At 1 January 2024
and 31 December 2024 112,756
AMORTISATION
At 1 January 2024 67,653
Amortisation for year 22,551
At 31 December 2024 90,204
NET BOOK VALUE
At 31 December 2024 22,552
At 31 December 2023 45,103

MEDOVATE LIMITED (REGISTERED NUMBER: 10894990)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


5. TANGIBLE FIXED ASSETS
Fixtures
Leasehold Plant and and Computer
improvements machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 January 2024 7,529 - 9,726 22,910 40,165
Additions - 2,321 - - 2,321
Disposals (7,529 ) - - - (7,529 )
At 31 December 2024 - 2,321 9,726 22,910 34,957
DEPRECIATION
At 1 January 2024 7,529 - 8,689 22,101 38,319
Charge for year - 580 655 808 2,043
Eliminated on disposal (7,529 ) - - - (7,529 )
At 31 December 2024 - 580 9,344 22,909 32,833
NET BOOK VALUE
At 31 December 2024 - 1,741 382 1 2,124
At 31 December 2023 - - 1,037 809 1,846

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 33,129 20,699
Other debtors - 22,200
VAT 9,452 -
Prepayments and accrued income 28,841 45,030
71,422 87,929

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 9,715 3,291
Amounts owed to group undertakings 577,512 -
Social security and other taxes 13,602 7,307
VAT - 2,424
Accruals and deferred income 33,736 24,992
634,565 38,014

8. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Andrew Clifford (Senior Statutory Auditor)
for and on behalf of Shaw Gibbs (Audit) Limited

MEDOVATE LIMITED (REGISTERED NUMBER: 10894990)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


9. ULTIMATE CONTROLLING PARTY

The parent undertaking of the smallest and largest group within which the company belongs and for which group accounts are prepared is Lunovi Limited, a company registered in England. A copy of the group accounts can be obtained from its registered office: C/O JEB Technologies, Hampstead Avenue, Mildenhall, Suffolk, IP28 7AS.

The ultimate holding company is Lunovi LLC, a company registered in the USA.